Keywords: kissei, starts, phase, trials, kvx-478, pharmaceutical, started

Kissei starts Phase I trials of KVX-478

Article | 29 May 1995

Print This

- Kissei Pharmaceutical has started Japanese Phase I trials of KVX-478, an oral protease inhibitor for treating HIV infection licensed from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in